De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 Signaling
Catherine Del Vecchio Fitz(Whitehead Institute for Biomedical Research), Piyush B. Gupta(Broad Institute)
Cited by 114
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
|Nature Communications|2017|138
SMART COVID Navigator, a Clinical Decision Support Tool for COVID-19 Treatment: Design and Development Study
|Journal of Medical Internet Research|2021|9